Livzon Pharmaceutical Group (HK:1513) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Livzon Pharmaceutical Group successfully held its 2024 Third Extraordinary General Meeting on November 26, where all proposed resolutions were approved by shareholders. Despite certain shareholders abstaining due to material interests, the meeting witnessed significant participation with 498,347,082 shares carrying voting rights. This approval underscores the company’s strong shareholder engagement and governance practices.
For further insights into HK:1513 stock, check out TipRanks’ Stock Analysis page.
